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Within the adult mammalian heart distinct types of TRP 
channels are expressed (as both homo- and hetero-tetramers) 
in a number of different cell types. These include: i) cardiac 
myocytes, ii) fibroblasts/myofibroblasts, iii) endothelial 
cells, iv) smooth muscle myocytes and v) both intrinsic 
and autonomic neurons and varicosities. Our previous 
work focused on TRP channel expression, phenotypes 
and functional properties in fibroblasts/myofibroblasts 
from rat ventricle and human atrium. Our overall goal 
was to detect and define fundamental steps in excitation-
secretion (E-S) coupling in these cells. An initial focus was 
on transmembrane Ca2+ influx and related intracellular 
Ca2+-induced Ca2+ release. Recently it has been reported by 
Harada et al, that Ca2+ influx through TRPC channels in 
human atrial À broblasts represents an essential signal for 
the fibroblast to myofibroblast transition that develops in 
the setting of atrial À brillation (cf. Rose et al, 2012).
This presentation will summarize our multidisciplinary 
experimental work and related mathematical modeling 
directed toward the question:  Can the known TRP channel 
expression provide the trigger Ca2+ signal for E-S coupling in 
mammalian heart À broblasts/myoÀ broblasts?
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Calcium/calmodulin-dependent phosphatase calcineurin, 
which signals to nuclear factor of activated T cells (NFAT) 
transcription factors, serves as a transducer of Ca2+ signals 
and is sufficient and necessary for pathological cardiac 
hypertrophy and remodeling. Transient receptor potential 
(TRP) proteins regulate entry of cation including Ca2+ into 
cells in response to a variety of signals. We showed that 
TRPC6 is up-regulated in mouse hearts in response to 
activated calcineurin, pressure-overload and genetic deletion 
of natriuretic peptide receptor 1 (Npr1), as well as in failing 
human hearts. Two conserved NFAT consensus sites in 
the promoter of the TRPC6  gene confer responsiveness to 
cardiac stress. Cardiac-specific TRPC6 transgenic mice 
results in abnormal cardiac growth and heart failure. 
Inhibition of TRPC activities by using a selective blocker 
BTP2 ameliorated hypertrophic responses in Npr1 knockout 
mice and mice treated with angiotensin II. Furthermore 
we found that atrial natriuretic peptide (ANP) inhibits 
TRPC6 activity by phosphorylating threonine 69, thereby 
exerting anti-hypertrophic effects in the heart. These results 
implicate TRPC6 as a key component of a Ca2+-dependent 
regulatory loop that drives maladaptive cardiac hypertrophy, 
and a potential therapeutic target against pathological 
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Brugada syndrome is a rare cardiac arrhythmia disorder, 
characterized by coved-type ST elevation in the right 
precordial leads and ventricular fibrillation without 
underling structural heart diseases. It has been described 
as a monogenic disorder with mutations in SCN5A (cardiac 
sodium channel Nav1.5) in around 20% of cases. Through 
a genome-wide association study of 312 individuals with 
Brugada syndrome and 1,115 controls, with independent 
replication studies using Caucasian and Japanese cohorts, 
we conÀ rmed three signiÀ cant association signals at SCN5A, 
SCN10A  (neuronal sodium channel Nav1.8) and near the 
transcription factor HEY2  gene. The cumulative effect of 
the three loci on disease susceptibility was unexpectedly 
large. Despite the controversy about the expression levels 
of SCN10A  in the heart, and the pathophysiological 
significance of its rare coding variations in Brugada 
syndrome, common intronic polymorphisms of SCN10A 
directly enhance the promoter of SCN5A  both in mice 
and human. These results indicate that common genetic 
variation can have a strong impact on the predisposition 
to rare diseases, and open a new era of investigation in the 
complex genetic architecture in cardiac arrhythmias.
JS-4  TRPV2 is crucial for cardiac 
structure and function
Yuki Katanosaka
Cardiovascular Physiol., Grad. Sch. Med., Dent. and Pharmaceut. Sci., 
Okayama Univ.
The heart has a dynamic compensatory mechanism for 
haemodynamic stress. However, the molecular details of 
myocardial mechanotransduction have remained unclear. 
Previously, we reported that recombinant TRP vanilloid 
family type 2 channels (TRPV2) can be activated by 
hypotonicity- and stretch-induced mechanical stimulation 
in ectopic expression systems. Interestingly, TRPV2 is 
highly localized to mammalian cardiac intercalated discs. 
To elucidate the physiological role of cardiac TRPV2, we 
generated temporally-controlled cardiac-specific TRPV2-
deficient mice. Here we show that TRPV2 is critical for 
the maintenance of cardiac structure and function. Within 
4 days of eliminating TRPV2 from adult mouse hearts, 
cardiac function declined severely, with disorganization 
of intercalated discs that support mechanical coupling 
with neighbouring myocytes. TRPV2-deficient neonatal 
myocytes showed no intracellular Ca2+ increase and IGF-
1 secretion after stretch-stimulation. The IGF-1 receptor/
PI3K/Akt signalling pathway was significantly down-
regulated in TRPV2-deÀ cient hearts. IGF-1 administration 
partially prevented chamber dilation and impairment in 
cardiac pump function in these hearts. These results provide 
a molecular basis for maintaining cardiac structure and 
function.23
JS-5  ROS-generating TRPC 
channels in cardiac remodeling
Motohiro Nishida1,2,3,4, Naoyuki Kitajima1,2, 
Akiyuki Nishimura1, Takuro Tomita1,4
1Div. Cardiocirc., Signal., Okazaki Inst. Integr. Biosci. (Nat. Inst. Physiol., 
Sci.), 2Dept. Translat. Pharmaceut. Sci., Grad. Sch. Pharm. Sci., Kyushu Univ., 
3JST, PRESTO, 4Dept. Physiol. Sci., SOKENDAI
Mechanical stretch during diastolic filling of the heart 
activates the mechanotransduction signalling pathways that 
have broad implications for adaptation and maladaptation 
of the heart against hemodynamic load. Recent papers 
have shown that a diastolic stretch of myocytes induces 
local production of reactive oxygen species (ROS) via 
NADPH oxidase 2 (Nox2) and enhances Ca2+ signalling 
in cardiomyocytes. However, the underlying mechanism 
is still obscure. We demonstrate that local Ca2+ influx 
through canonical transient receptor potential subfamily 
3 (TRPC3) channels contribute to Nox2-mediated ROS 
production induced by mechanical stress in rodent 
cardiomyocytes. Although TRPC3 and TRPC6 apparently 
form heteromultimer channels that mediate pressure 
overload-induced cardiac hypertrophy, but only TRPC3 
protein is found to up-regulate Nox2 protein levels by 
forming protein complex. Deletion of TRPC3 significantly 
suppressed Nox2 expression, ROS production, and diastolic 
dysfunction induced by pressure overload in mouse hearts. 
These results strongly suggest that TRPC3 participates in 
chronic mechano-chemo transduction in rodent hearts, and 
will be a promising therapeutic target for the treatment of 
heart failure.
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